期刊
NEUROLOGY
卷 66, 期 6, 页码 919-921出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000204294.28189.03
关键词
-
资金
- NCRR NIH HHS [M01 RR00044] Funding Source: Medline
- NIAID NIH HHS [U01 AI27658] Funding Source: Medline
- NIMH NIH HHS [P01 MH64570, R01 MH64409] Funding Source: Medline
In vitro and animal model data demonstrate that valproic acid (VPA) can ameliorate HIV-associated neurotoxicity. The authors conducted a pilot 10-week placebo-controlled study of VPA 250 mg twice daily in 22 HIV-infected individuals with (n = 16) and without (n = 6) cognitive impairment. VPA was safe and well tolerated, with trends toward improved neuropsychological performance and brain metabolism in the impaired subjects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据